Posts

Sculpting quantum materials for the electronics of the ...

The development of new information and communication technologies poses new chal...

Top-down control of bottom-up material synthesis @ nano...

In a new publication from Opto-Electronic Advances, 10.29026/oea.2023.230023 Pro...

Instrument adapted from astronomy observation helps cap...

By adapting technology used for gamma-ray astronomy, a group of experimental res...

Link between chronic kidney disease and cardiovascular ...

Researchers from Tokyo Medical and Dental University (TMDU) have uncovered a lin...

FDA approves first-ever at-home test for both COVID and...

The first over-the-counter, at-home test that can identify both COVID-19 and inf...

$370M bid by Olympus for the acquisition of Taewoong Me...

Olympus has made a $370M bid to acquire Taewoong Medical.  An updated plan was h...

Moderna skin cancer medication gets FDA approval

Moderna announced that U.S. authorities have approved its experimental personali...

Life Sciences Voice Top Five Newsletter- March 2023

This week we take a look at FDA’s approval for the first home test kit, how soci...

FDA considers clearance for neuromodulation device as T...

The FDA is considering granting de novo clearance for a device aimed at treating...

Bayer, J&J’s Xarelto Shown to Reduce Ischemia Risk For ...

Patients suffering from peripheral arterial disease (PAD) frequently require low...

FDA approves Abbott’s latest lab blood test for concussion

The Food and Drug Administration (FDA) has cleared Abbott’s laboratory blood tes...

The Future of Gene Therapies: Three Trends

“Maps don’t show you where you will go in life, they show you where you might go...

Servier’s acquisition of Agios’ INDIGO trial bears posi...

French drugmaker Servier recently acquired Agios Pharmaceutical’s cancer unit fo...

FDA Advisory Committee Recommends Agency Approve Two RS...

Two RSV vaccinations targeted toward elders, one from Pfizer and one from GSK, h...

US FDA approves Novartis’ Tafinlar and Mekinist combina...

The approval of the combination of Tafinlar and Mekinist is based on the Phase I...

UCB enters drug discovery collaboration with Aitia

The collaboration will combine the use of new drug targets for the disease from ...